The Susceptibility of <i>Klebsiella Pneumoniae</i> Strains Isolated from COVID-19 Patients to Commercially Available Bacteriophage Medications

Background. Superinfection caused by Klebsiella pneumoniae occupies a leading position in the structure of bacterial complications in COVID-19 patients. The intensive circulation of Klebsiella in specialised hospitals has contributed to the consolidation of the most clinically and epidemiologically...

Full description

Saved in:

Bibliographic Details
Main Authors:	B. I. Aslanov, A. E. Goncharov, S. D. Konev, A. S. Mochov, D. A. Azarov, E. А. Lebedeva, A. V. Kuleshova, V. V. Kolodzhieva, E. N. Kolosovskaya, A. M. Nifontova, D, A. Lioznov
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2025-04-01
Series:	Антибиотики и Химиотерапия
Subjects:	klebsiella pneumoniae phage therapy covid-19 sensitivity to bacteriophages spot test
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1206
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

The Susceptibility of <i>Klebsiella Pneumoniae</i> Strains Isolated from COVID-19 Patients to Commercially Available Bacteriophage Medications

Similar Items